![](/img/cover-not-exists.png)
E05Review of RAISE, a Randomized, Double-Blind, Multicenter Phase III Study of Irinotecan, Folinic Acid, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (RAM) or Placebo (PBO) in Patients (pts) With Metastatic Colorectal Carcinoma (mCRC) Progressive During or Following First-Line Combination Therapy With Bevacizumab (bev), Oxaliplatin (ox), and a Fluoropyrimidine (fp): Primary Results and Subgroup Analysis by KRAS Status
Sobrero, A., Latini, L., Barone, C., Capuzzo, F., Banzi, M., Nasroulah, F., Sims, L., Tabernero, J.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv340.05
Date:
October, 2015
File:
PDF, 34 KB
english, 2015